The FDA and other policymakers should take immediate action to ensure the integrity of the FDA's rigorous regulatory review and approval process, the drug supply chain and decades of carefully balanced approaches to fostering innovation and generic competition. Eli Lilly, Novo Nordisks rival in the diabetes and obesity market, also is expected to launch a weight-loss pill, orforglipron, in the first half of this year
Other GLP-1 medications include liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Structured programs incorporating dietary counseling, physical activity guidance, and behavioral therapy can help maintain weight loss
The most common include: Nausea Vomiting Diarrhoea Constipation Bloating You may also notice: Changes in food preferences Fatigue Loss of appetite appetite suppression is expected with both medications
Additionally, 5-Amino-1MQ may help preserve lean muscle mass during fat loss by optimizing energy utilization